Prognosis
U.S. to Supply Covid Drugs Based on Cases Amid Delta Surge
- Hospitals no longer able to order monoclonal antibodies
- Use of drugs had spiked in states with unvaccinated pockets
This article is for subscribers only.
The U.S. government plans to more directly control where Covid-19 antibody treatments are sent amid a surge in infections and hospitalizations in states with large pockets of unvaccinated people.
Hospitals and other care providers will no longer be able to directly order monoclonal antibody therapies from distributors, according to a Sept. 13 update posted on the Department of Health and Human Services website.